+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Biotech Market Size, Share and Growth Outlook, 2026: Analysis By Technology (DNA Sequencing and Genomics, Nanobiotechnology, Tissue Engineering and Regeneration, PCR Technology, Fermentation and Bioprocessing, Chromatography and Separation, Cell-Based Assays, CRISPR and Gene-Editing Tools), By Application (Health and Red Biotechnology, Food and Agriculture , Industrial Processing , Environmental and Natural Resources , Bioinformatics and Omics), By Product Type (Biopharmaceuticals, Bioprocess Equipment and Consumables, Reagents and Kits, Bioservices, Bioinformatics Platforms and Software), By End-User (Biopharmaceutical and Biotechnology Companies, Contract Research Organizations , Academic and Research Institutes, Hospitals and Diagnostic Centers, Agricultural Corporations) Companies, and Country Forecast, 2021 to 2034

Global Biotech Market size is forecast to increase from $2380.44 Billion in 2026 to $6373.21 Billion in 2034 at a CAGR of 13.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005957
Pages: 214 Pages

Biosurgery Market Size, Share and Growth Outlook, 2026: Analysis By Product (Bone-Graft Substitutes, Hemostatic Agents, Surgical Sealants and Adhesives, Adhesion Barriers, Soft-Tissue Attachments, Staple-Line Reinforcement), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Biosurgery Market size is forecast to increase from $29.77 Billion in 2026 to $43.65 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005956
Pages: 218 Pages

Biosolids Market Size, Share and Growth Outlook, 2026: Analysis By Type (Class A, Class A EQ, Class B), By Form (Cakes, Liquid, Pellets), By Application (Agriculture Land Application, Non-Agriculture Land Application, Energy Recovery), By Source (Municipal Utilities, Industrial Facilities) Companies, and Country Forecast, 2021 to 2034

Global Biosolids Market size is forecast to increase from $1.98 Billion in 2026 to $2.77 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005955
Pages: 223 Pages

Biosimulation Market Size, Share and Growth Outlook, 2026: Analysis By Product (Software, Services), By Delivery Model (Subscription, Ownership ), By Application (Pre-clinical and Clinical Drug Development, Drug Discovery and Lead Optimization, Precision Medicine and Companion Diagnostics Design), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations , Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Biosimulation Market size is forecast to increase from $5.22 Billion in 2026 to $17.47 Billion in 2034 at a CAGR of 16.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005954
Pages: 229 Pages

Biosimilars Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Monoclonal Antibodies, Insulins, Recombinant Human Growth Hormones, Granulocyte Colony-Stimulating Factors , Erythropoietin, Anticoagulants , Fusion Proteins), By Manufacturing Type (In-house Manufacturing, Outsourced), By Route of Administration (Intravenous , Subcutaneous , Oral & Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare) Companies, and Country Forecast, 2021 to 2034

Global Biosimilars Market size is forecast to increase from $40.8 Billion in 2026 to $71.16 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005953
Pages: 210 Pages

Biosimilar Monoclonal Antibodies Market Size, Share and Growth Outlook, 2026: Analysis By Product (Infliximab Biosimilars, Rituximab Biosimilars, Trastuzumab Biosimilars, Adalimumab Biosimilars, Bevacizumab Biosimilars, Ranibizumab Biosimilars, Other Pipeline Products), By Indication (Oncology, Autoimmune & Inflammatory Diseases, Ophthalmic Disorders, Hematologic Disorders, Bone Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Biosimilar Monoclonal Antibodies Market size is forecast to increase from $17.57 Billion in 2026 to $79.15 Billion in 2034 at a CAGR of 20.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005952
Pages: 220 Pages

Biosimilar Contract Manufacturing Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Upstream Processing, Downstream Processing, Process Development, Bioassay & Biosimilarity Testing, Fill & Finish Operations), By Expression System (Mammalian Systems, Microbial Systems, Others ), By Product Type (Monoclonal Antibodies , Recombinant Non-glycosylated Proteins , Recombinant Glycosylated Proteins ), By Application (Oncology, Chronic & Autoimmune Disorders, Blood Disorders, Infectious Diseases, Metabolic Disorders) Companies, and Country Forecast, 2021 to 2034

Global Biosimilar Contract Manufacturing Market size is forecast to increase from $10.6 Billion in 2026 to $30.66 Billion in 2034 at a CAGR of 14.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005951
Pages: 226 Pages

Biosensors Market Size, Share and Growth Outlook, 2026: Analysis By Technology Type (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, Nanomechanical Biosensors), By Product Category (Wearable Biosensors, Non-Wearable Biosensors), By Component (Bioreceptor Molecules , Transducers and Signal Processing Units), By End-Use Application (Point-of-Care , Home Healthcare Diagnostics, Research Laboratories, Food and Beverage Testing, Environmental Monitoring, Biodefense and Security Systems) Companies, and Country Forecast, 2021 to 2034

Global Biosensors Market size is forecast to increase from $39.55 Billion in 2026 to $82.95 Billion in 2034 at a CAGR of 9.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005950
Pages: 217 Pages

Biosensors in Life Sciences Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal ), By Product Type (Wearable Bio-sensing Devices, Non-Wearable ), By Application (Drug Discovery and Development, Genomics and Proteomics Research, Cell Culture and Fermentation Analysis, Clinical Trial Testing), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Biosensors in Life Sciences Market size is forecast to increase from $24.08 Billion in 2026 to $44.9 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005949
Pages: 225 Pages

Bioresorbable Vascular Scaffold Market Size, Share and Growth Outlook, 2026: Analysis By Product (Drug-Eluting Bioresorbable Scaffolds, Bare Bioresorbable Scaffolds), By Material Type (Polymer-Based Scaffolds, Metallic-Based Scaffolds), By Application (Coronary Artery Interventions, Peripheral Artery Interventions), By End-User (Hospitals and Cardiac Centers, Ambulatory Surgical Centers , Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Bioresorbable Vascular Scaffold Market size is forecast to increase from $567.06 Million in 2026 to $1977.63 Million in 2034 at a CAGR of 16.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005948
Pages: 230 Pages